Obesity

Latest News
October 24th 2024

Medicaid Budget Survey Highlights Postpandemic Challenges and Priorities

October 24th 2024

How to Address, Prevent Childhood Obesity in the US

October 23rd 2024

How Sugar, Ultraprocessed Foods Are Shaping the Health of America's Youth

September 24th 2024

Semaglutide Improves Hidradenitis Suppurativa in Patients With Obesity

September 24th 2024

Semaglutide Accessibility and Affordability Addressed at Senate Committee Hearing

Video Interviews
View All
August 2nd 2024

GLP-1 Agonists and the Gut-Brain Axis: A New Era in Obesity Management

January 17th 2024

Dr Ian Neeland Explores Semaglutide Alternatives and Strategies in Cases of Nonresponse

January 15th 2024

Jeff McIntyre Raises NASH Awareness Among Health Care Community

January 15th 2024

Dr Ian Neeland Discusses Uptick in Patients Seeking Semaglutide for Weight Loss

January 10th 2024

Dr Ian Neeland Explains Why Semaglutide Shortage Impacts Injectable and Not Oral Version

January 7th 2024

Dr Ian Neeland on Oral Semaglutide as a Backup Amid Injection Shortage

January 3rd 2024

Dr Ian Neeland Describes Patient Experience During Semaglutide Shortage

December 20th 2023

Dr Peter Katzmarzyk Addresses Social Determinants of Obesity, Proposes Collaborative Support

More News

Syringe, pills, and measuring tape | Image credit: adragan – stock.adobe.com
September 20th 2024

5 Things Americans Should Know About Weight Loss Drugs

Hayden E. Klein
Weight loss drugs have gained attention as a tool to help combat obesity, but understanding how they work, who they’re for, and their potential downsides is key to making informed decisions.
Blood pressure | Image credit: CasanoWa Stutio - stock.adobe.com
September 5th 2024

Weight Loss Surgery Associated With Blood Pressure Control

Julia Bonavitacola
Patients who had weight-loss surgery were more likely to have managed their high blood pressure compared with those who used medications and modes of management.
Cleveland, OH Image credit: SeanPavonePhoto – stock.adobe.com
August 16th 2024

How Can We Improve Obesity Care in 2024 and Beyond?

Hayden E. Klein
At an Institute for Value-Based Medicine® (IVBM) event cohosted by The American Journal of Managed Care®, experts discussed efforts to implement obesity management science into practice.
Wegovy injections | Image credit: K KStock – stock.adobe.com
August 6th 2024

Rising Costs Lead Insurers to Drop Weight Loss Drug Coverage, Further Increasing Patient Burden

Hayden E. Klein
The growing list of insurers dropping coverage for costly GLP-1 weight loss drugs leaves patients to bear even higher out-of-pocket expenses while still struggling to meet their goals.
AJMC
August 5th 2024

Inadequate Insurance Coverage for Overweight/Obesity Management

Eden Miller, DO Steve Edelman, MD Carlos Campos, MD, PA John E. Anderson, MD Christopher G. Parkin, MS William H. Polonsky, PhD, CDCES
This article reviews the obesity epidemic in America and discusses inadequate insurance coverage.
AJMC
July 29th 2024

An Efficient Approach to Expand Equitable Access to Antiobesity Medications: Deprescribing After Weight Loss Plateau

David D. Kim, PhD A. Mark Fendrick, MD
The authors advocate for a consideration of 2 distinct phases of obesity management (ie, active weight loss and maintenance of weight loss) to allow substantially more people access to antiobesity medications.
Semaglutide Ozempic injection blood sugar obesity | Image Credit: © myskin - stock.adobe.com
March 6th 2024

Can Different Pricing Models Address the Obesity Problem in America?

Julia Bonavitacola
Getting weight loss drugs into the hands of those who need them could be a matter of changing pricing models to give more patients access to the medication they need.
Woman breastfeeding | Image credit: bernardbodo – stock.adobe.com
January 17th 2024

Early Breastfeeding May Reduce Baby’s Risk of Childhood Obesity

Hayden E. Klein
Breastfeeding infants during the first 3 months can lower their risk of childhood obesity, regardless of the mother's body mass index before pregnancy.
Bariatric surgery | Image credit: Olivier Le Moal – stock.adobe.com
January 15th 2024

Study Reveals How the ACA Impacted Roux-en-Y Gastric Bypass Utilization

Hayden E. Klein
Despite there being more patients undergoing bariatric surgery since the Affordable Care Act (ACA) was enacted in 2010, these surgeries had better postoperative outcomes.
what we're reading logo
January 8th 2024

What We’re Reading: Mask Mandates Return; Sugary Drink Sales Decline; WIC Program Problems

AJMC Staff
COVID-19 subvariant JN.1 accounts for about 62% of US cases, resulting in mask mandates being reinstated in cities across the United States; sugary drink sales fell dramatically across 5 US cities after implementing taxes on them; it is difficult for Special Supplement Nutrition Program for Women and Children (WIC) participants to find approved items.
Ozempic injection | Image credit: mbruxelle – stock.adobe.com
December 21st 2023

An Ongoing Crisis: Semaglutide Shortage Raises Dual Concerns for Obesity and Diabetes Treatment

Hayden E. Klein
An in-depth look into what the drug is being used for and what has contributed to the shortage.
obese woman talking to doctor | Image credit: Studio Romantic - stock.adobe.com
December 19th 2023

Obesity, Women’s Health, Health Equity Among Top Benefit Focuses for Employers in 2024

Skylar Jeremias
A new survey from the National Alliance of Healthcare Purchaser Coalitions found that employers are planning to place a larger focus on obesity management, women’s health, and health equity in 2024 and beyond.
what we're rading logo
December 13th 2023

What We’re Reading: Childhood Obesity Counseling; Humana Lawsuit; AI Use Concern

AJMC Staff
The US Preventive Services Task Force (USPSTF) recommended that children with obesity receive intensive counseling at age 6 to promote healthy diet and exercise habits; a new survey found that the majority of American patients are wary of their doctors using artificial intelligence (AI); a class-action lawsuit was filed Tuesday against health insurer Humana for using an AI algorithm that systemically denies seniors rehabilitation care recommended by their doctors.
What We’re Reading: House Passes Controversial Health Care Package; Insurers Tighten Ozempic Coverage; Arizona Court to Hear Arguments on Near-Total Abortion Ban
December 12th 2023

What We’re Reading: House Passes Health Care Package; Insurers Tighten Ozempic Coverage; Arizona Court to Hear Abortion Arguments

AJMC Staff
End-of-year victory for lawmakers as health care policies pass in the House; insurance limitations prompt concerns over access to semaglutide (Ozempic) for diabetes; a legal battle ensues over the fate of abortion laws in Arizona.
what we're reading logo
December 6th 2023

What We’re Reading: Weight Loss Drug Adherence; Free Birth Control Access; Organ Transplant Test Access

AJMC Staff
Data analysis showed that 40% of patients who filled a prescription for Wegovy in 2021 or 2022 were still taking it a year later; both Democrats and reproductive rights organizations are pressuring the Biden administration to ensure health insurers fully cover contraception; CMS implemented Medicare changes in March that limited access to blood tests that help transplant recipients ensure their organs remain healthy.
Hydrocodone Pills and Prescription - Andy Dean - stock.adobe.com
December 5th 2023

Obesity Advocates Challenge FDA Over Drug Approval Process Disparities

Giuliana Grossi
The Obesity Action Coalition and other organizations are urging the FDA to address critical gaps in drug testing, emphasizing the need for specific testing in individuals with obesity to ensure safety and efficacy, as current practices expose this population to unnecessary risks.
What We’re Reading: Nursing Homes Without COVID-19 Boosters; Racial Discrimination in Health Care; New Obesity Treatment Hits Market
December 5th 2023

What We’re Reading: Low Rates of COVID-19 Boosters in Nursing Homes; Racial Discrimination in Health Care; New Obesity Treatment

AJMC Staff
Low vaccination rates raise fears of COVID-19 resurgence; a survey highlights racial discrimination in health care; Eli Lilly’s tirzepatide (Zepbound) has entered US pharmacies.
AJMC
November 1st 2023

Characterizing Obesity in a Large Health Care Delivery System

Alice Pressman, PhD, MS JB Jones, PhD, MBA Xiangyi Xu, MS Alexandra Scott, MA Sara Alvarez, PharmD Stephanie Watkins, PhD Emily Durden, PhD
The prevalence of obesity in the Sutter Health system between 2015 and 2020 was 35%. Differences by race/ethnicity, health insurance, smoking status, and comorbidities were examined.
Doctor measuring obese man waist body fat. Obesity and weight loss: © JPC-PROD - stock.adobe.com
August 2nd 2023

Research Explores Role of Waist Circumference, Obesity in Hypertension Subtypes

Gianna Melillo
Findings were presented by researchers from the UC Irvine Health School of Medicine at the 2023 American Society for Preventive Cardiology's Congress on CVD Prevention.
scale with measuring tape wrapped around it
July 12th 2023

Patients With Overweight or Obesity Show Significant Weight Loss in Phase 2 Survodutide Trial

Hayden E. Klein
After receiving 4.8 mg of survodutide weekly for 46 weeks, more than half of trial participants achieved weight loss of 15% or more.
Childhood obesity word cloud: © ibreakstock - stock.adobe.com
June 28th 2023

Digital Learning Could Prevent Obesity in Low-Income Children

Gwen Mergian
Overall, home visitation staff support the use of technology-enhanced educational tools in conjunction with home visits to promote positive weight outcomes.
coffee and newspaper
June 16th 2023

What We’re Reading: FDA Panel Suggests COVID-19 Vaccine Updates; BMI Insufficient as Health Measure; Teens Seek Obesity Treatments

AJMC Staff
Independent FDA panel advises that the next round of COVID-19 vaccines only target XBB strains; the American Medical Association (AMA) says that only using body mass index (BMI) is not enough to evaluate health; teens with severe obesity look to controversial surgery and weight-loss drugs.
coffee and newspaper
April 27th 2023

What We’re Reading: Weight Loss Results for Mounjaro; 8-Year Drug Shortage; Bacterial Outbreak Kills 4

Justina Petrullo
Type 2 diabetes drug tirzepatide (Mounjaro) helped some individuals lose nearly 16% of their body weight; some vital drugs have been sporadically in shortage for over 8 years; a bacterial outbreak of klebsiella claimed 4 lives and infected 31 people in a Seattle hospital.
12>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo